Financial Performance - The company's operating revenue for 2019 was CNY 1,016,378,796.96, representing a 17.62% increase compared to CNY 864,138,782.82 in 2018[24]. - The net profit attributable to shareholders for 2019 was CNY 161,493,339.26, a 36.06% increase from CNY 118,696,797.76 in 2018[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 145,789,629.47, up 47.52% from CNY 98,828,121.65 in 2018[24]. - The basic earnings per share for 2019 was CNY 0.72, reflecting a 35.85% increase from CNY 0.53 in 2018[24]. - The total assets at the end of 2019 amounted to CNY 2,045,383,667.36, a 4.53% increase from CNY 1,956,721,003.04 at the end of 2018[24]. - The net cash flow from operating activities for 2019 was CNY 170,688,672.64, a decrease of 22.67% compared to CNY 220,735,744.07 in 2018[24]. - The weighted average return on equity for 2019 was 15.00%, an increase of 2.49% from 12.51% in 2018[24]. - Total revenue for the year reached ¥1,016,368,796.96, with a significant increase in the fourth quarter to ¥520,886,705.57, representing a quarterly growth of 236.5%[29]. - Net profit attributable to shareholders for the fourth quarter was ¥77,258,617.44, marking a substantial increase compared to previous quarters, with a total annual net profit of ¥161,493,439.26[29]. - The company reported a net cash flow from operating activities of ¥294,034,388.82 in the fourth quarter, a significant turnaround from negative cash flow in the first three quarters[29]. Market Expansion and Projects - The company successfully won bids for two major projects under the National Medical Insurance Bureau, enhancing its competitive position in the new medical insurance landscape[40]. - The company expanded its healthcare services by acquiring five new tier-three hospitals as clients and implementing multiple large-scale smart hospital projects across various provinces[40]. - The company developed a comprehensive subsidy supervision system for financial aid to the public, which has been successfully implemented in 15 cities in Sichuan province[42]. - The company added three new core housing fund system clients and six comprehensive service platform clients, contributing to its market expansion in housing finance[44]. - The company has made significant progress in the "Smart People's Congress" project in Chengdu, which is expected to become a new growth point for the company[45]. - The company has actively expanded its market presence in the healthcare sector, enhancing collaboration with medical institutions[61]. - The company is involved in major projects such as the National Medical Insurance Bureau's information platform, which enhances its industry understanding and innovation capabilities[52]. Research and Development - Research and development expenses increased significantly, contributing to a reduction in corporate income tax due to enhanced R&D tax deductions[61]. - The company’s R&D investment amounted to CNY 122,875,971.18, representing 12.09% of operating revenue, a decrease of 0.94% compared to the previous year[89]. - The number of R&D personnel increased by 23.86% to 654, with R&D personnel accounting for 21.69% of the total workforce[89]. - The company plans to continue advancing major R&D projects in healthcare, digital governance, smart cities, and military-civilian integration[88]. - The total R&D investment amounted to CNY 33,884,184.25, with significant projects in technology platform development and digital governance research[92]. Financial Management and Investments - The total operating cost for the reporting period was CNY 511,762,596.97, with direct materials accounting for 35.02%, direct labor for 42.24%, and manufacturing expenses for 22.74%[1]. - The company’s financial expenses decreased by 15.55% to CNY -7,361,688.01, mainly due to reduced interest expenses on bank loans[87]. - The company reported a significant increase in its financial assets, with a reclassification resulting in an increase of 280 million CNY in trading financial assets[174]. - The company completed a non-public offering of 12,540,592 A-shares, raising 47.95 million yuan from the employee stock ownership plan, with 1,342,385 shares subscribed[184]. Profit Distribution - The company has maintained a consistent profit distribution policy, ensuring the protection of minority investors' rights while balancing shareholder returns with long-term development[153]. - The company proposed a profit distribution plan for 2019, distributing a cash dividend of 2.00 CNY per 10 shares, totaling 44,860,553.80 CNY, which represents 27.78% of the net profit attributable to ordinary shareholders[154]. - The cash dividend in 2019 was the highest in the last three years, reflecting the company's strong financial performance[154]. - The company’s cash dividends have shown a steady increase in relation to its net profits over the years, indicating a commitment to returning value to shareholders[154]. Risks and Challenges - The company faces potential risks in its future operations, which investors should be aware of[7]. - The company faces increasing market competition as more domestic and international enterprises enter the livelihood information technology sector, posing a significant risk to its competitive advantage[139]. - Rising labor costs due to inflation and increasing average wage levels present a significant operational cost risk for the company[141]. - The company may face a decline in service charge standards for its operational services due to market expansion and increased competition, impacting revenue[142]. - Changes in government policies regarding investment in the livelihood information sector could adversely affect the company's operations and market demand[143]. - Rapid growth has led to increased management complexity, requiring higher management capabilities to maintain operational efficiency[144]. - The company faces risks related to talent retention as competition for skilled professionals intensifies, which could hinder future business development[145]. Compliance and Governance - The company has not encountered any significant changes in the measurement attributes of major assets during the reporting period[107]. - The company has maintained a continuous audit relationship with Lixin Accounting Firm for 11 years, with an audit fee of 750,000 CNY for the reporting period[177]. - The company has not faced any situations that could lead to suspension or termination of its listing following the annual report disclosure[178]. - The company has committed to avoiding any business competition with its subsidiaries, ensuring no direct or indirect competition that could affect operations[164]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[169].

Financial Performance - Net profit attributable to shareholders was CNY 22,321,535.75, representing a 39.50% increase year-on-year[8]. - Operating revenue for the period reached CNY 154,720,350.88, an increase of 23.30% compared to the same period last year[8]. - The company reported a net profit of CNY 84,234,721.82 for the year-to-date, an increase of 41.69% compared to the same period last year[8]. - Basic earnings per share were CNY 0.100, reflecting a 7.53% increase year-on-year[8]. - The total comprehensive income attributable to the parent company was ¥22,321,535.75, compared to ¥16,000,766.82 in the previous period, showing an increase of approximately 39.5%[66]. - Net profit for the current period reached ¥90,919,309.76, an increase of 35.9% compared to ¥66,964,415.62 in the previous period[81]. - The net profit for the current period was ¥17,705,039.40, compared to ¥10,012,221.87 in the previous period, indicating a significant increase of about 76.9%[67]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,943,591,242.63, a decrease of 0.67% compared to the end of the previous year[8]. - The company's current assets totaled CNY 1,569,317,057.70, down from CNY 1,610,432,248.67 at the end of 2018, indicating a decrease of approximately 2.6%[35]. - Total liabilities decreased to CNY 784,690,248.96 from CNY 842,304,171.13, representing a reduction of approximately 6.8%[41]. - The company's equity attributable to shareholders increased to CNY 1,060,545,570.49, up from CNY 1,019,445,996.67, indicating a growth of about 4%[44]. - Total assets decreased slightly to ¥1,721,563,096.25 from ¥1,742,419,668.62, a decline of 1.2%[54]. - Total liabilities decreased to ¥711,967,575.45 from ¥763,849,225.96, a reduction of 6.8%[54]. - Owner's equity increased to ¥1,009,595,520.80, up from ¥978,570,442.66, reflecting a growth of 3.1%[54]. Cash Flow - The net cash flow from operating activities was CNY 26,187,459.71, a decrease of 52.09% compared to the previous year[8]. - Cash flow from operating activities showed a negative net amount of ¥-123,345,716.18, a decrease of 363.13% due to reduced cash received from sales and other operational activities[20]. - The net cash flow from operating activities was negative CNY 60,907,204.85, worsening from negative CNY 48,288,478.52 year-over-year[98]. - Cash inflows from investment activities reached CNY 419,292,097.40, significantly up from CNY 3,153,000.00 in the previous period[98]. - The net cash flow from investment activities was positive CNY 79,283,208.56, a turnaround from negative CNY 325,248,131.70 in the prior year[98]. - The net cash flow from financing activities was negative CNY 43,820,148.00, compared to a positive CNY 392,367,311.41 in the prior period[101]. Research and Development - Research and development expenses surged by 212.88% to ¥39,875,050.46, reflecting increased investment in R&D projects[18]. - Research and development expenses increased to ¥14,296,172.07, compared to ¥4,381,993.43, marking a rise of 226.5%[55]. - Research and development expenses surged to ¥34,096,814.27, significantly higher than ¥6,363,411.16 in the previous period, indicating a focus on innovation[84]. Shareholder Information - The total number of shareholders at the end of the reporting period was 10,390, with the largest shareholder holding 26.29%[12]. - The company did not engage in any repurchase transactions during the reporting period[15]. Government Support - The company received government subsidies amounting to CNY 6,695,750.27 during the reporting period[8]. - The company recorded other income of ¥6,695,750.27, up from ¥6,325,371.59, reflecting an increase of approximately 5.9%[74]. Operational Costs - Total operating costs amounted to ¥135,334,390.66, up from ¥113,308,042.86, reflecting a growth of 19.4%[55]. - The total operating costs for the current period were ¥396,912,217.47, compared to ¥354,121,823.46 in the previous period, representing an increase of about 12.1%[74]. - The company reported a decrease in operating costs to ¥177,495,566.81 from ¥209,360,430.90 in the previous period, improving margins[82]. Future Plans - The company plans to continue expanding its market presence and invest in new technologies and products[60]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[85].

Financial Performance - The company's operating revenue for the first half of 2019 was CNY 340,771,740.51, representing a 15.14% increase compared to CNY 295,958,551.88 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was CNY 61,913,186.07, a 42.50% increase from CNY 43,449,318.46 year-on-year[22]. - The net profit after deducting non-recurring gains and losses was CNY 60,155,176.82, up 53.98% from CNY 39,066,610.09 in the previous year[22]. - The basic earnings per share increased to CNY 0.28, a rise of 47.37% compared to CNY 0.19 in the same period last year[22]. - The total profit for the period was RMB 77.37 million, up 28.39% compared to the previous year[51]. - The company reported a 240.10% increase in revenue from the military-civilian integration sector, reaching ¥21,400,210.04 compared to ¥6,292,417.12 in the previous year[56]. - The revenue from software products surged by 64.55% to ¥169,491,302.92 from ¥103,000,370.80, highlighting strong demand in this segment[56]. - Revenue from the healthcare and medical insurance sector reached ¥133,595,525.12, with a year-on-year increase of 11.19%[62]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,875,005,049.62, down 4.18% from CNY 1,956,721,003.04 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company were CNY 1,038,224,034.74, reflecting a 1.84% increase from CNY 1,019,445,996.67 at the end of the previous year[22]. - The company's total assets amounted to RMB 1.875 billion, a decrease of 4.18% year-on-year, while net assets increased by 1.84% to RMB 1.038 billion[51]. - The company's current assets totaled CNY 1,516,696,836.38, down from CNY 1,610,432,248.67 at the end of 2018, indicating a decrease of about 5.8%[186]. - Total liabilities decreased to CNY 739,354,154.09 from CNY 842,304,171.13, a reduction of about 12.3%[192]. - The company's equity attributable to shareholders increased to CNY 1,038,224,034.74 from CNY 1,019,445,996.67, showing a growth of approximately 1.8%[192]. Cash Flow - The company reported a net cash flow from operating activities of CNY -149,533,175.89, which is a decline of 83.94% compared to CNY -81,296,439.62 in the same period last year[22]. - The company’s cash flow from operating activities showed a significant decline, with a net cash flow of -RMB 149.53 million, down 83.94% year-on-year[51]. - Cash and cash equivalents decreased by 140.54% to -¥107,651,418.46 from ¥265,526,668.37, reflecting a significant drop in cash inflows[56]. Strategic Focus - The company focuses on four strategic directions: healthcare insurance, digital government, smart cities, and military-civilian integration[32]. - The company secured multiple contracts for the National Medical Security Bureau's information platform, enhancing its competitive advantage in the healthcare sector[35]. - The company has successfully implemented the DRGs project across various provinces, indicating a comprehensive coverage in the healthcare sector[36]. - The company launched a subsidy supervision system for financial aid, benefiting over 1.5 million people with a total disbursement of nearly RMB 2 billion[39]. - The company expanded its market presence in digital governance, supporting over 100 cities with stable operation of human resources core business systems[37]. Research and Development - The company increased its development expenditure by RMB 18.87 million, a growth of 66.67%, reflecting a commitment to R&D[41]. - Research and development expenses increased by 6.15% to ¥46,630,790.07 from ¥43,931,165.10, indicating continued investment in innovation[52]. - The company plans to increase R&D investment in solution and industry product areas to maintain technological leadership and mitigate risks associated with policy changes[93]. Market and Competition - The company faces intensified market competition due to increased government focus on public welfare and the growing demand for "Internet + healthcare" services[92]. - The company aims to maintain rapid growth in newly developed markets by leveraging its competitive advantages and adopting differentiated service strategies[92]. Governance and Compliance - The company has committed to avoiding any direct or indirect competition with its controlling shareholder, ensuring compliance with relevant laws and regulations[111]. - There were no significant litigation or arbitration matters during the reporting period, indicating a stable legal environment for the company[116]. - The company has not experienced any penalties or corrective actions during the reporting period, reflecting good governance practices[124]. Shareholder Information - The company reported a participation rate of 42.61% in the first extraordinary shareholders' meeting held on April 12, 2019[101]. - The company’s largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 28.35% of the shares, and there may be a change in the actual controller due to ongoing equity changes[147]. - The total number of common shareholders at the end of the reporting period was 9,227[157]. - The total shares held by the top ten shareholders include significant stakes from state-owned entities[161]. - The company’s major shareholders have not changed during the reporting period[165].

四川久远银海软件股份有限公司 2019 年第一季度报告全文 四川久远银海软件股份有限公司 2019 年第一季度报告 2019-022 2019 年 04 月 1 四川久远银海软件股份有限公司 2019 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人连春华、主管会计工作负责人杨成文及会计机构负责人(会计主 管人员)张昕声明：保证季度报告中财务报表的真实、准确、完整。 2 四川久远银海软件股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |-----------------------------------------------------|------------------|------------------|---------------------------| | ...

Financial Performance - The company's operating revenue for 2018 was CNY 864,138,782.82, representing a 25.16% increase compared to CNY 690,447,976.82 in 2017[24] - The net profit attributable to shareholders of the listed company was CNY 118,696,797.76, up 30.73% from CNY 90,795,508.19 in the previous year[24] - The net profit after deducting non-recurring gains and losses was CNY 98,828,121.65, an increase of 14.63% compared to CNY 86,212,128.00 in 2017[24] - The net cash flow from operating activities was CNY 220,735,744.07, reflecting a significant increase of 58.72% from CNY 139,076,410.79 in 2017[24] - The total assets at the end of 2018 reached CNY 1,956,721,003.04, a 50.79% increase from CNY 1,297,610,972.99 at the end of 2017[24] - The net assets attributable to shareholders of the listed company were CNY 1,019,445,996.67, showing a 100.67% increase from CNY 508,020,996.44 in 2017[27] - The basic earnings per share for 2018 was CNY 0.69, which is a 21.05% increase from CNY 0.57 in the previous year[24] - The diluted earnings per share also stood at CNY 0.69, reflecting the same growth of 21.05% compared to CNY 0.57 in 2017[24] - The weighted average return on equity was 12.51%, down 6.30% from 18.81% in 2017[24] Cash Flow and Investments - The net cash flow from operating activities in the fourth quarter was ¥247,368,753.19, indicating a strong recovery from negative cash flow in the first quarter[29] - The company received government subsidies amounting to ¥18,500,387.96, a substantial increase from the previous year[30] - The company reported a gain of ¥4,652,846.99 from the acquisition of subsidiaries, indicating successful investments in new ventures[30] - The company’s operating cash inflow for 2018 reached ¥980,714,683.05, a year-on-year increase of 28.29% compared to ¥764,432,349.99 in 2017[85] - Investment cash inflow decreased significantly by 99.52% to ¥62,937.23, primarily due to the absence of short-term investment maturity and equity recovery from an associate company[88] - Net cash flow from investing activities saw a drastic decline of 1,003.23%, resulting in a net outflow of ¥429,724,335.36[89] - Financing cash inflow doubled to ¥440,843,350.47, attributed to a non-public stock issuance[90] - Net cash flow from financing activities surged by 912.95% to ¥389,097,732.18, compared to a net outflow of ¥47,862,500.00 in the previous year[88] - The net increase in cash and cash equivalents for 2018 was ¥180,109,140.89, reflecting a 244.62% increase from ¥52,262,423.76 in 2017[88] Revenue Breakdown - Total revenue for the fourth quarter reached ¥442,693,978.66, with a year-on-year increase compared to previous quarters[29] - Net profit attributable to shareholders for the fourth quarter was ¥59,246,712.48, showing significant growth from earlier quarters[29] - The revenue from the smart city and digital government sector was CNY 498.05 million, representing a 41.58% increase year-on-year[56] - The healthcare and medical insurance sector generated CNY 316,348,175.11 in revenue, reflecting a 37.53% increase year-on-year[60] - Revenue from system integration business grew significantly, contributing to a total revenue of CNY 864.14 million, a 25.16% increase year-on-year[54] - The total revenue from system integration services was CNY 282,532,251.09, with a year-on-year growth of 61.27%[64] Research and Development - Research and development expenses increased by 49.81% to 44,837,071.04 yuan due to increased investment in R&D[79] - The company’s R&D investment reached 112,565,252.69 yuan, a 77.03% increase from the previous year, representing 13.03% of operating revenue[81] - The number of R&D personnel increased by 34.01% to 528, making up 20.09% of the total workforce[81] - The company is focusing on major R&D projects in healthcare, digital governance, smart cities, and military-civilian integration[80] - The company has completed several R&D projects, including the Urban-Rural Social Security Software Product Upgrade Project, which is now in the market promotion phase[84] Strategic Focus and Market Position - The strategic focus was upgraded to four key areas: healthcare insurance, digital governance, smart cities, and military-civilian integration[128] - The company aims to expand its market presence in healthcare, civil affairs, and housing finance sectors, leveraging its existing competitive advantages[128] - The company has implemented several key projects in "Internet Medical Insurance" and "Medical Big Data," enhancing its service offerings[40] - New healthcare solutions leveraging big data and AI have been developed, including clinical decision support and intelligent medical order management[40] - The company has expanded its digital governance services, supporting various government departments in enhancing their operational capabilities[41] Acquisitions and Investments - The company acquired 60% of Beijing Yinhai Zheqi Technology Co., Ltd. for CNY 4,900,000.00, obtaining a 60% stake[71] - The company acquired 80% of Sichuan Health Jiuyuan Technology Co., Ltd. for CNY 17,700,000.00, with a fair value of identifiable net assets at CNY 20,239,718.68, resulting in a loss of CNY 2,539,718.68[168] - The company acquired 60% of Hangzhou Hailiang Information Technology Co., Ltd. for CNY 42,000,000.00, with a fair value of identifiable net assets at CNY 7,241,581.17, resulting in goodwill of CNY 34,758,418.83[168] - The company established Tianjin Jiuyuan Health Technology Co., Ltd. with a registered capital of CNY 5,100,000, holding a 51% stake[176] - The company set up Kashgar Yinhai Dingfeng Software Co., Ltd. with an investment of CNY 1,000,000, which is a wholly-owned subsidiary[177] Dividend Policy - The company distributed a cash dividend of 2.50 yuan per 10 shares, totaling 43,135,148 yuan for the year 2018, which represents 36.34% of the net profit attributable to ordinary shareholders[145] - The total distributable profit for the year 2018 was 247,161,662 yuan, with the cash dividend constituting 100% of the profit distribution[146] - The company has maintained a consistent cash dividend policy, ensuring the protection of minority shareholders' rights and balancing reasonable returns with long-term development[139] - The cash dividend for 2017 was also 43,135,148 yuan, accounting for 47.51% of the net profit attributable to ordinary shareholders[145] - The company did not propose any stock dividends or additional share distributions in the 2017 and 2018 profit distribution plans[141] Risks and Challenges - The company faces risks from intensified market competition as more players enter the civil informationization sector[128] - There is a risk of technological development not keeping pace with policy changes, which could impact the company's competitive edge[128] - Rising operational costs due to inflation and increased labor costs pose a significant risk to the company's profitability[132] - The company is at risk of declining service fees in its operation and maintenance services due to market maturity and competition[131] - The company acknowledges the challenge of maintaining talent stability amidst increasing competition for skilled professionals in the IT sector[133]

Financial Performance - Operating revenue for the current period was CNY 125,486,252.28, a year-on-year increase of 12.23%[8] - Net profit attributable to shareholders for the current period was CNY 16,000,766.82, representing a year-on-year increase of 42.77%[8] - The estimated net profit attributable to shareholders for 2018 is projected to be between ¥99.88 million and ¥127.11 million, representing a year-on-year increase of 10.00% to 40.00%[26] - The net profit for 2017 attributable to shareholders was ¥90.80 million[26] - The stable growth in revenue is attributed to sectors such as social security, big data, and housing provident fund[26] Asset and Equity Changes - Total assets increased by 35.58% to CNY 1,759,308,076.98 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 89.01% to CNY 960,199,284.20 compared to the end of the previous year[8] - Prepaid accounts increased by 283.37% to ¥22,164,436.23 due to higher advance payments for supplier materials[17] - Other current assets surged by 17,619.60% to ¥237,726,514.77 primarily from increased VAT input tax credits and short-term financial products[17] - Investment properties rose by 374.26% to ¥46,403,602.60 as a result of converting fixed assets into investment properties[17] - Fixed assets increased by 31.58% to ¥97,145,904.90 due to new office purchases[17] Cash Flow Analysis - Net cash flow from operating activities increased significantly by 467.54% to CNY 54,663,430.50[8] - Net cash flow from operating activities improved by 57.01% to -¥27,993,134.12, driven by a 50.58% increase in cash received from sales[18] - Net cash flow from investing activities worsened by 1,003.56% to -¥350,830,978.70, mainly due to cash outflows for fixed asset purchases and subsidiary acquisitions[18] - Net cash flow from financing activities increased by 966.21% to ¥391,397,311.41, attributed to funds raised from a private placement of shares[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,143[12] - The largest shareholder, Sichuan Jiuyuan Investment Group Co., Ltd., holds 26.29% of the shares[12] - The company did not engage in any repurchase transactions during the reporting period[13] Research and Management Activities - The company conducted two institutional research activities on May 16, 2018, and July 20, 2018[29] - The company has engaged in entrusted wealth management with a total amount of ¥230 million, all of which is from raised funds[30] - There are no overdue amounts or expected impairments related to entrusted wealth management[30] Compliance and Commitments - The company has no overdue commitments from controlling shareholders or related parties during the reporting period[24] - There are no violations regarding external guarantees during the reporting period[27] - The company has no non-operating fund occupation by controlling shareholders or related parties during the reporting period[28] - The company has no significant or low-security entrusted wealth management situations during the reporting period[30] R&D and Expenses - R&D expenses decreased by 31.56% to ¥12,744,401.69, reflecting reduced capitalization of R&D expenditures[18] - The company reported non-recurring gains and losses totaling CNY 7,161,926.03 for the current period[9]

Financial Performance - The company's operating revenue for the first half of 2018 was CNY 295,958,551.88, representing a 23.01% increase compared to CNY 240,605,632.44 in the same period last year[17]. - The net profit attributable to shareholders of the listed company was CNY 43,449,318.46, up 24.29% from CNY 34,956,908.17 year-on-year[17]. - The net profit after deducting non-recurring gains and losses was CNY 39,066,610.09, an increase of 18.42% compared to CNY 32,990,317.41 in the previous year[17]. - The basic earnings per share for the first half of 2018 was CNY 0.26, an increase of 18.18% from CNY 0.22 in the same period last year[17]. - The total profit reached 6,026.15 CNY, reflecting a 29.02% year-on-year growth, while net profit was 4,971.13 CNY, up 27.61% year-on-year[39]. - The company reported a net profit of CNY 60,261,480.58 for the first half of 2018, reflecting a significant increase from CNY 45,159,560.15 in the same period last year[144]. - The total comprehensive income for the period was CNY 49,711,300.28, an increase of 27.67% compared to CNY 38,956,448.90 in the previous year[145]. Assets and Liabilities - The company's total assets at the end of the reporting period reached CNY 1,738,974,084.72, a 34.01% increase from CNY 1,297,610,972.99 at the end of the previous year[17]. - The net assets attributable to shareholders of the listed company increased by 85.86% to CNY 944,198,517.37 from CNY 508,020,996.44 at the end of the previous year[17]. - The total liabilities decreased slightly to CNY 689,226,397.19 from CNY 693,723,342.42 at the beginning of the year[142]. - The equity attributable to the parent company increased to CNY 931,222,389.28, up from CNY 495,687,885.63 at the start of the year[142]. Cash Flow - The company reported a net cash flow from operating activities of CNY -81,296,439.62, which is a decline of 61.79% compared to CNY -50,247,976.80 in the previous year[17]. - The company's operating cash flow net amount was negative CNY 81,296,439.62, worsening from negative CNY 50,247,976.80 in the same period last year[152]. - The total cash inflow from financing activities was 440,330,000.00 yuan, while cash outflow was 5,567,540.59 yuan, resulting in a net cash flow of 434,762,459.41 yuan[156]. - The company’s cash and cash equivalents increased by 265,526,668.37 yuan during the period, contrasting with a decrease of 113,096,398.55 yuan in the previous period[155]. Investment and Development - The company has reported an increase in development expenditures by ¥18,925,335.04, reflecting higher investments in research and development projects[35]. - The company invested 86,305,177.24 yuan in fixed assets and intangible assets, compared to 20,851,232.43 yuan in the previous period, showing a substantial increase in capital expenditure[155]. - The company plans to enhance its core competitiveness by increasing R&D investment and market expansion to address intensified market competition in the "Internet + Healthcare" sector[75]. - The company has allocated CNY 44,287,483.98 for development expenditures, indicating a focus on innovation and product development[141]. Strategic Focus - The company operates in three strategic sectors: healthcare and medical insurance, digital government and smart cities, and military-civilian integration, providing various information technology solutions and services[25]. - The company is focusing on three strategic units: "Healthcare and Medical Insurance," "Digital Government and Smart Cities," and "Smart Institutions and Military-Civilian Integration," enhancing its industry positioning as a service provider for public welfare and national defense[33]. - The company is actively advancing three fundraising projects related to medical insurance services and military-civilian integration, with positive outcomes already observed in multiple regions[32]. Shareholder Information - The company will not distribute cash dividends or issue bonus shares for the half-year period[83]. - The total share capital increased from 160,000,000 shares to 172,540,592 shares after the issuance of 12,540,592 new shares[116]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 26.29% of the shares, totaling 45,355,200 shares[119]. Risks and Challenges - The company faces risks related to technology leakage and will enhance internal management and establish information security mechanisms to mitigate this risk[77]. - Rising operational costs are a concern due to increasing labor costs driven by inflation and social development; the company aims to maximize the efficiency of its expenditures through lean management[77]. - The company anticipates a potential decline in service fees for its operation and maintenance services due to market expansion and increased competition, and plans to invest in R&D to offer diverse solutions[77]. Compliance and Governance - The company adheres to the accounting standards, ensuring that the financial statements accurately reflect the financial position, operating results, and cash flows for the reporting period[178]. - The financial report for the first half of 2018 was not audited[133]. - There were no significant litigation or arbitration matters during the reporting period[88].

Financial Performance - The company's operating revenue for Q1 2018 was ¥121,629,652.73, representing a 30.65% increase compared to ¥93,097,596.91 in the same period last year[8] - The net profit attributable to shareholders was ¥8,331,977.12, up 21.11% from ¥6,879,726.76 year-over-year[8] - The net profit after deducting non-recurring gains and losses was ¥6,035,110.80, reflecting a 17.97% increase from ¥5,115,935.55 in the previous year[8] - The basic earnings per share for the period was ¥0.048, a 20.00% increase from ¥0.040 in the same period last year[8] - The diluted earnings per share also stood at ¥0.048, reflecting a 20.00% increase year-over-year[8] - The net profit attributable to shareholders for the first half of 2018 is expected to increase by 10.00% to 30.00%, ranging from 38.45 million to 44.54 million CNY[23] - The net profit for the first half of 2017 was 34.96 million CNY, indicating a positive growth trend[23] Cash Flow and Assets - The net cash flow from operating activities was -¥95,763,477.50, a decrease of 63.62% compared to -¥58,527,684.08 in the same period last year[8] - Cash and cash equivalents increased by 47.33% to ¥856,552,869.24 due to funds raised from a private placement of shares[15] - The net cash flow from financing activities surged to ¥435,975,000.00, a significant increase attributed to funds raised from the private placement of shares[16] - Total assets at the end of the reporting period reached ¥1,690,118,215.29, a 30.25% increase from ¥1,297,610,972.99 at the end of the previous year[8] - The net assets attributable to shareholders increased by 88.24% to ¥956,315,977.07 from ¥508,020,996.44 at the end of the previous year[8] Expenses and Investments - Research and development expenses increased by 30.86% to ¥37,659,431.16, reflecting higher investment in R&D projects[15] - The company recorded a 64.93% decrease in taxes payable to ¥8,130,811.11, due to reduced corporate income tax and VAT payments[15] - Investment properties increased by 389.14% to ¥47,859,033.81, resulting from new property acquisitions for rental purposes[15] - The company reported government subsidies amounting to ¥2,686,279.09 during the reporting period[9] Other Financial Metrics - The weighted average return on equity was 1.27%, slightly down from 1.31% in the previous year[8] - The company reported a 177.39% increase in prepaid accounts to ¥16,036,884.03, mainly due to higher advance payments to suppliers[15] - The company’s goodwill increased to ¥964,128.44 following the acquisition of Beijing Zheqi Heming Technology Co., Ltd.[15] - The company did not report any overdue commitments from shareholders or related parties during the reporting period[22] Growth Drivers - The growth in performance is primarily driven by the continuous growth in information technology services in the public welfare sector, healthcare, military industry, and big data business[23]

Financial Performance - The company's operating revenue for 2017 was ¥690,447,976.82, representing a 30.91% increase compared to ¥527,433,146.18 in 2016[16] - The net profit attributable to shareholders for 2017 was ¥90,795,508.19, up 17.51% from ¥77,266,341.24 in 2016[16] - The net cash flow from operating activities increased by 77.05% to ¥139,076,410.79 in 2017, compared to ¥78,553,399.43 in 2016[16] - Basic earnings per share for 2017 were ¥0.57, an increase of 18.75% from ¥0.48 in 2016[16] - Total assets at the end of 2017 reached ¥1,297,610,972.99, a 15.82% increase from ¥1,120,339,351.91 at the end of 2016[17] - The net assets attributable to shareholders increased by 11.11% to ¥508,020,996.44 at the end of 2017, compared to ¥457,225,488.25 at the end of 2016[17] - The company reported a weighted average return on equity of 18.81% for 2017, up from 17.62% in 2016[16] - The company experienced a significant increase in net profit after deducting non-recurring gains and losses, which rose by 24.13% to ¥86,212,128.00 in 2017[16] Dividend Distribution - The company plans to distribute a cash dividend of ¥2.50 per 10 shares, totaling approximately ¥43,135,148.00 based on 172,540,592 shares[4] - In 2017, the cash dividend represented 47.51% of the net profit attributable to shareholders, which was 90,795,508.19 yuan[96] - The cash dividends for 2016 and 2015 were 40,000,000 yuan each, representing 51.77% and 69.90% of the respective net profits[96] - The company did not distribute any stock dividends or increase capital from reserves in the 2017 fiscal year[94] - The company has not proposed any cash dividend distribution plan for the current reporting period despite having positive distributable profits[96] Business Operations - The company operates in two main business areas: "civilian" and "military," focusing on software products and services related to big data, health, and military-civilian integration[26] - The company is a leading provider of information technology solutions in the human resources and social security sector, and a strategic partner of the Ministry of Human Resources and Social Security[29] - The company has developed a comprehensive solution for the health care sector, connecting government, enterprises, and the public, covering various aspects of health services[29] - The company is positioned as a key player in the military information technology sector, collaborating with major military groups and the National Defense Science and Technology Industry Bureau[31] Research and Development - Research and development (R&D) investment rose by 37.29% to ¥63,585,538.82, accounting for 9.21% of operating revenue[56] - The company has over 300 proprietary intellectual properties and has participated in the formulation of more than 20 national and industry standards[28] - The company is actively involved in the development of a domestic controllable computing environment, showcasing several applications at the 2017 Chengdu Smart Expo[32] Market and Competition - The company’s market coverage extends to 23 provinces, with significant contributions from the Southwest region, accounting for 65.25% of total revenue[43] - The company anticipates a market size growth of over 20% in the military-civilian integration sector over the next five years, driven by government policies[80] - The company faces risks from intensified market competition as more players enter the civil information sector, which could challenge its competitive advantages[81] Financial Management - The company reported a net cash outflow from financing activities of ¥47,862,500.00, a decrease of 263.80% compared to the previous year, due to the absence of financing activities in the current period[60] - The company raised a total of ¥229,200,000.00 through its initial public offering, with a net amount of ¥189,050,027.70 after deducting fees[68] - The company has committed a total investment of CNY 18,910.5 million in various projects, with a cumulative investment of CNY 11,344.48 million, achieving an investment progress of approximately 60%[72] Corporate Governance - The company has maintained a continuous relationship with its accounting firm, which has provided audit services for 9 years[105] - The company has not experienced any major accounting errors requiring retrospective restatement during the reporting period[103] - The company has a policy ensuring that cash dividends will not be less than 20% of the total profit distribution in cases of significant capital expenditures[96] Employee Relations - The company emphasizes employee rights and welfare, adhering to various labor laws and providing comprehensive benefits[127] - The company has implemented a strict salary policy based on labor laws, ensuring timely and accurate payment of employee wages[181] - The company has established an employee charity fund to assist employees facing sudden hardships, such as serious illnesses[128] Internal Controls - The company reported no significant internal control deficiencies during the reporting period, indicating effective internal governance[198] - The company has established robust anti-fraud procedures and control measures to mitigate risks[199] - The financial report process has been controlled adequately, ensuring the accuracy of financial statements[199] Shareholder Information - The total share capital increased from 80,000,000 shares to 160,000,000 shares after the capital reserve conversion and profit distribution[143] - The number of shareholders holding more than 5% of shares includes Sichuan Jiuyuan Investment Holding Group with 28.35% and Sichuan Science City Ruifeng Group with 12.97%[145] - The company distributed 6,000,000 shares to shareholders as part of the profit distribution plan, effective from September 21, 2017[143]

Financial Performance - Operating revenue for the reporting period was CNY 111,809,689, representing a year-on-year increase of 68.60%[8] - Net profit attributable to shareholders was CNY 11,207,276, an increase of 37.91% compared to the same period last year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 10,787,164.53, up 184.32% year-on-year[8] - Basic earnings per share for the reporting period were CNY 0.1160, reflecting a growth of 14.17%[8] - The weighted average return on equity was 2.53%, an increase of 0.48 percentage points compared to the previous year[8] - The company’s minority shareholders' profit increased significantly by 592.48% to ¥8.93 million, driven by higher net profits from subsidiaries[17] - The net profit attributable to shareholders for 2017 is expected to be between 84.99 million and 108.17 million CNY, representing a growth of 10.00% to 40.00% compared to 77.27 million CNY in 2016[24] - The company maintains stable growth in its main business operations, contributing to the positive profit outlook for 2017[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,111,700,650, a decrease of 0.77% compared to the end of the previous year[8] - The company’s total assets decreased by 100% in long-term equity investments, dropping to ¥0 from ¥4.06 million, due to the sale of equity in an affiliated company[16] - The company’s total liabilities increased, with accounts payable rising by 84.98% to ¥62.46 million, attributed to increased payments to suppliers[16] Cash Flow - The net cash flow from operating activities was negative CNY 14,872,673.41, a decline of 440.21% compared to the same period last year[8] - The company reported a net cash flow from operating activities of -¥65.12 million, a decrease of 2.09% compared to -¥63.79 million in the previous year[17] - The company’s cash flow from financing activities showed a significant decline of 253.61%, dropping to -¥45.19 million from a positive cash flow of ¥29.41 million in the previous year[17] Shareholder Information - The total number of shareholders at the end of the reporting period was 10,938[12] - The largest shareholder, Sichuan Jiuyuan Investment Group Co., Ltd., held 28.35% of the shares[12] Research and Development - Research and development expenses increased by 78.22% to ¥29.62 million from ¥16.62 million, reflecting increased investment in R&D projects[16] Other Financial Metrics - The company reported a total of CNY 2,386,702.24 in non-recurring gains and losses for the year-to-date[9] - The company’s investment income improved by 50.18%, with losses reduced to -¥976,198.09 from -¥1.96 million year-on-year[17] - Accounts receivable rose by 38.85% to ¥121.91 million, primarily due to the expansion of the company's business scale and new sales[16] - The company plans to raise up to ¥500 million through a private placement of shares, with proceeds allocated to various healthcare service projects[18]